CHU de Nimes
Nîmes, 30029, France
NCT Number: NCT04043871
The investigators hypothesize that the Systolic Foot-to-Apex Time Interval (SFATI) method will be accurate for measurement of systolic blood pressure with marked arterial stiffness as seen in patients with severe renal impairment. Also that the presence of arterial calcifications only changes the agreement between the SFATI method and the reference method (auscultatory method) if the calcifications are very severe.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Nîmes, 30029, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Systolic blood pressure measured by Foot-to-Apex Systolic Interval, conventional oscillometric measurement, and the auscultatory method
Time frame: Day 0
mmHg measured by Systolic Foot-to-Apex Time Interval
Time frame: Day 0
mmHg measured by auscultatory method
Time frame: Day 0
m/s
Time frame: Day 0
mmHg; Dinamap
Time frame: Day 0
Measured by ultrasound of the arteries of the upper limb
Time frame: Day 0
Yes/No, measured by Complior > 10 m/s
Time frame: Day 0
Age, sex, diabetes, Chronic Renal Disease stage
Time frame: Day 0
Change in antihypertensive treatment following measurement
Centre Hospitalier Universitaire de Nīmes
Other
Concordance Between the Foot-to-Apex Systolic Interval and the Auscultatory Method for Measurement of Brachial Systolic Pressure in Patients With Severe Renal Failure: Pilot Study
Acronym: SFATI-IRC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05936138
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Miami, Florida, United States
View Trial DetailsNCT06890208
Anxiety Disorders, Arrhythmias, Cardiac
Hamburg, Germany
View Trial DetailsNCT04876963
Arrhythmias, Cardiac, Cardiovascular Diseases
Copenhagen, Denmark
View Trial DetailsNCT07165015
Chronic Disease, Disease Attributes
Orlando, Florida, United States
View Trial Details